Trial Profile
A phase I trial of single and multiple doses of NOX A12 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Dec 2011
Price :
$35
*
At a glance
- Drugs Olaptesed pegol (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- Sponsors NOXXON Pharma AG
- 15 Dec 2011 New trial record